Bristol Myers Squibb Stock Price - BMY

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 54.77 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.35 0.64% 54.77 54.8205 53.87 54.46 54.42 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
66,680 13,165,181 $ 54.26 $ 714,387,772 9,501,360 41.19 - 57.37
Last Trade Time Type Quantity Stock Price Currency
18:58:26 37 $ 54.99 USD

Bristol Myers Squibb Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 89.59B 1.64B $ 4.92B 3.01 13.00 1.63B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
149.51M $ 1.61 2.94% 10/03/19 10.00 0.40%

more financials information »

Bristol Myers Squibb News

Latest BMY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BMY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week51.9557.3751.2953.2813,725,3322.825.43%
1 Month50.0157.3748.5551.3410,812,8334.769.52%
3 Months44.3757.3744.0048.9310,757,75810.4023.44%
6 Months45.3457.3741.1947.1912,271,0249.4320.8%
1 Year50.5257.3741.1948.4713,847,3784.258.41%
3 Years50.1170.0541.1952.819,572,3624.669.3%
5 Years52.0077.1241.1955.968,439,9962.775.33%

Bristol Myers Squibb Description

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.
Your Recent History
NYSE
BMY
Bristol My..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191024 04:10:50